Michael Catlin - 18 Mar 2024 Form 4 Insider Report for Kiromic Biopharma, Inc. (KRBPQ)

Role
Director
Signature
/s/ Mike Catlin
Issuer symbol
KRBPQ
Transactions as of
18 Mar 2024
Net transactions value
$0
Form type
4
Filing time
20 Mar 2024, 17:58:13 UTC
Previous filing
06 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRBP Restricted Stock Award Award +18,000 +240% 25,500 18 Mar 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted a restricted stock award which vests on the one year anniversary of the date of grant.